相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome
Eric R. Wengert et al.
BRAIN RESEARCH (2022)
Polyethyleneimine-Based Lipopolyplexes as Carriers in Anticancer Gene Therapies
Julia Jerzykiewicz et al.
MATERIALS (2022)
Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives
Matthis Synofzik et al.
NUCLEIC ACID THERAPEUTICS (2022)
Changes in brain activity with tominersen in early-manifest Huntington's disease
D. J. Hawellek et al.
BRAIN COMMUNICATIONS (2022)
Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics
Markus Herkt et al.
MOLECULAR THERAPY (2021)
Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
Julien Dugal-Tessier et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
The Risks of miRNA Therapeutics: In a Drug Target Perspective (vol 15, pg 721, 2021)
S. Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
The infinite possibilities of RNA therapeutics
Evelyn C. Mollocana-Lara et al.
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2021)
Rapid Sequencing-Based Diagnosis of Thiamine Metabolism Dysfunction Syndrome
Mallory J. Owen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
CRISPR diagnostics
Omar O. Abudayyeh et al.
SCIENCE (2021)
The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular Atrophy
Amber N. Edinoff et al.
ORTHOPEDIC REVIEWS (2021)
Chemistry of Peptide-Oligonucleotide Conjugates: A Review
Kristina Klabenkova et al.
MOLECULES (2021)
An overview of precision oncology basket and umbrella trials for clinicians
Jay J. H. Park et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
Fadwa Odeh et al.
MOLECULES (2020)
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Abishek Wadhwa et al.
PHARMACEUTICS (2020)
Generation and validation of structurally defined antibody-siRNA conjugates
Alex R. Nanna et al.
NUCLEIC ACIDS RESEARCH (2020)
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
Kian Huat Lim et al.
NATURE COMMUNICATIONS (2020)
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Garam Kim et al.
NEURON (2020)
Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome
Zhou Han et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Targeting RNA: A Transformative Therapeutic Strategy
Wei Yin et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Mutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons
Scott Bell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
Meenu Mehta et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
CRISPR/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool
Deepak Kumar Sahel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
S. K. Hassel et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Veena Mathew et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
Polina Denichenko et al.
NATURE COMMUNICATIONS (2019)
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
Jeroen Bremer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Oligonucleotide designed for ultimate personalized treatment
Ian Fyfe
NATURE REVIEWS NEUROLOGY (2019)
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Fibrin-hyaluronic acid hydrogel-based delivery of antisense oligonucleotides for ADAMTS5 inhibition in co-delivered and resident joint cells in osteoarthritis
Joao Pedro Garcia et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Antiviral Activity of a New Class of Chemically Modified Antisense Oligonucleotides against Influenza A Virus
A. Markov et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2019)
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Carlo Rinaldi et al.
NATURE REVIEWS NEUROLOGY (2018)
RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases
Hanns Lochmueller et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
A Half-Century History of Applications of Antisense Oligonucleotides in Medicine, Agriculture and Forestry: We Should Continue the Journey
Volodymyr V. Oberemok et al.
MOLECULES (2018)
Improving Small Interfering RNA Delivery In Vivo Through Lipid Conjugation
Maire F. Osborn et al.
NUCLEIC ACID THERAPEUTICS (2018)
Aptamers in the Therapeutics and Diagnostics Pipelines
Harleen Kaur et al.
THERANOSTICS (2018)
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
Hassan Javanbakht et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models
Kalyan Dulla et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis
Elaheh Ekhtiari Bidhendi et al.
ACTA NEUROPATHOLOGICA (2018)
The history and development of N-of-1 trials
R. D. Mirza et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2017)
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer
Jon Voutila et al.
MOLECULAR THERAPY (2017)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Oligonucleotide therapies for disorders of the nervous system
Olga Khorkova et al.
NATURE BIOTECHNOLOGY (2017)
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
Kathleen M. Schoch et al.
NEURON (2017)
Eteplirsen in the treatment of Duchenne muscular dystrophy
Kenji Rowel Q. Lim et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
Annemieke Aartsma-Rus et al.
NUCLEIC ACID THERAPEUTICS (2017)
Molecular Mechanisms of Antisense Oligonucleotides
Stanley T. Crooke
NUCLEIC ACID THERAPEUTICS (2017)
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Yuanyu Huang
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
Kim A. Lennox et al.
NUCLEIC ACIDS RESEARCH (2016)
Polymeric-based particulate systems for delivery of therapeutic proteins
Muhammad Sajid Hamid Akash et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2016)
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisenseoligonucleotides
Anthony J. Hinrich et al.
EMBO MOLECULAR MEDICINE (2016)
Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience
Manon Hache et al.
JOURNAL OF CHILD NEUROLOGY (2016)
Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
Tsukasa Sugo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
Mehdi Rezaee et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Applications of CRISPR technologies in research and beyond
Rodolphe Barrangou et al.
NATURE BIOTECHNOLOGY (2016)
Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model
Kathleen M. Schoch et al.
NEURON (2016)
The real cost of sequencing: scaling computation to keep pace with data generation
Paul Muir et al.
GENOME BIOLOGY (2016)
Drug delivery system of therapeutic oligonucleotides
Yutaro Asami et al.
DRUG DISCOVERIES AND THERAPEUTICS (2016)
Bioconjugates for targeted delivery of therapeutic oligonucleotides
Xin Ming et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Delivery of oligonucleotides with lipid nanoparticles
Yuhua Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
DVL1 Frameshift Mutations Clustering in the Penultimate Exon Cause Autosomal-Dominant Robinow Syndrome
Janson White et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems
Y. Wan et al.
CURRENT MEDICINAL CHEMISTRY (2015)
The roles of CRISPR-Cas systems in adaptive immunity and beyond
Rodolphe Barrangou
CURRENT OPINION IN IMMUNOLOGY (2015)
The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA
Timothy A. Vickers et al.
NUCLEIC ACIDS RESEARCH (2015)
Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease
Weibin Li et al.
NUCLEIC ACID THERAPEUTICS (2015)
siRNA Versus miRNA as Therapeutics for Gene Silencing
Jenny K. W. Lam et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Antisense Oligonucleotide Therapies: The Promise and the Challenges from a Toxicologic Pathologist's Perspective
Kendall S. Frazier
TOXICOLOGIC PATHOLOGY (2015)
CpG Oligonucleotides as Cancer Vaccine Adjuvants
Hidekazu Shirota et al.
VACCINES (2015)
Oligonucleotide-based therapy for neurodegenerative diseases
Iddo Magen et al.
BRAIN RESEARCH (2014)
Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Tommaso Iannitti et al.
CURRENT DRUG TARGETS (2014)
PEG - A versatile conjugating ligand for drugs and drug delivery systems
Atul Kolate et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Cell-penetrating peptides: 20 years later, where do we stand?
Cherine Bechara et al.
FEBS LETTERS (2013)
RNA-Based Therapeutics: Current Progress and Future Prospects
John C. Burnett et al.
CHEMISTRY & BIOLOGY (2012)
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2
Richard J. L. F. Lemmers et al.
NATURE GENETICS (2012)
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Ryszard Kole et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Oligonucleotide therapeutic approaches for Huntington disease
Dinah W. Y. Sah et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular Dystrophy
Qi-Long Lu et al.
MOLECULAR THERAPY (2011)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Antisense oligonucleotide pharmacokinetics and metabolism
Richard S. Geary
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease
Rosanne M. Seguin et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
siRNA and Innate Immunity
Marjorie Robbins et al.
OLIGONUCLEOTIDES (2009)
Impact of target mRNA structure on siRNA silencing efficiency: A large-scale study
Joseph A. Gredell et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Challenges and Opportunities for Local and Systemic Delivery of siRNA and Antisense Oligonucleotides
L. Sepp-Lorenzino et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
Elizabeth R. Rayburn et al.
DRUG DISCOVERY TODAY (2008)
Overcoming the innate immune response to small interfering RNA
Adam Judge et al.
HUMAN GENE THERAPY (2008)
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Rudy Juliano et al.
NUCLEIC ACIDS RESEARCH (2008)
Aptamer-based biosensors
Shiping Song et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2008)
Chemical modification: the key to clinical application of RNA interference?
David R. Corey
JOURNAL OF CLINICAL INVESTIGATION (2007)
Customized oligonucleotide microarray gene expression based classification of neuroblastoma patients outperforms current clinical risk stratification
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery
Maarja Mae et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Antisense oligonucleotides: From design to therapeutic application
JHP Chan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Chemical modification of gene silencing oligonucleotides for drug discovery and development
XL Chen et al.
DRUG DISCOVERY TODAY (2005)
Pegaptanib - In exudative age-related macular degeneration
MAA Siddiqui et al.
DRUGS (2005)
Toxicology of antisense therapeutics
TLH Jason et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Antisense morpholino-oligomers directed against the 5′ end of the genome inhibit coronavirus proliferation and growth
BW Neuman et al.
JOURNAL OF VIROLOGY (2004)
Innovations in oligonucleotide drug delivery
MA Lysik et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
A DNA aptamer as a new target-specific chiral selector for HPLC
M Michaud et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Cell-penetrating peptides - A reevaluation of the mechanism of cellular uptake
JP Richard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CpG-oligonucleotides for cancer immunotherapy: Review of the literature and potential applications in malignant glioma
AF Carpentier et al.
FRONTIERS IN BIOSCIENCE (2003)
Lipid-mediated delivery of oligonucleotide to pulmonary endothelium
Z Ma et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Design and characterization of decoy oligonucleotides containing locked nucleic acids
R Crinelli et al.
NUCLEIC ACIDS RESEARCH (2002)
Therapeutic applications of transcription factor decoy oligonucleotides
MJ Mann et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
